Bio Orbit

Bio Orbit

In-space drug manufacture, to enable the next generation of cancer care.

Company
Bio Orbit
Category
Spacetech, Biotech, Pharma
Portfolio
Fund 2
Date
2024

Leveraging microgravity, BioOrbit's in-space crystallisation of protein crystals is orders of magnitude more consistent than production on earth. Produced this way, drugs - including cancer antibodies like Keytruda - can be administered at home, rather than in a clinical setting, revolutionising the quality and accessability of care.

Bio Orbit
Bio Orbit